Cargando…

Oleoylethanolamide Exhibits GPR119-Dependent Inhibition of Osteoclast Function and GPR119-Independent Promotion of Osteoclast Apoptosis

Oleoylethanolamide (OEA), a bioactive lipid in bone, is known as an endogenous ligand for G protein-coupled receptor 119 (GPR119). Here, we explored the effects of OEA on osteoclast differentiation, function, and survival. While OEA inhibits osteoclast resorptive function by disrupting actin cytoske...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyun-Ju, Lee, Dong-Kyo, Jin, Xian, Che, Xiangguo, Choi, Je-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Molecular and Cellular Biology 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191045/ https://www.ncbi.nlm.nih.gov/pubmed/32050752 http://dx.doi.org/10.14348/molcells.2020.2260

Ejemplares similares

GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide
por: Im, Dong-Soon
Publicado: (2021)

β-Cell Inactivation of Gpr119 Unmasks Incretin Dependence of GPR119-Mediated Glucoregulation
por: Panaro, Brandon L., et al.
Publicado: (2017)

GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell
por: Lauffer, Lina M., et al.
Publicado: (2009)

GPR55 and GPR119 Receptors Contribute to the Processing of Neuropathic Pain in Rats
por: Zúñiga-Romero, Ángel, et al.
Publicado: (2022)

The estrogen-related receptor γ modulator, GSK5182, inhibits osteoclast differentiation and accelerates osteoclast apoptosis
por: Kim, Hyun-Ju, et al.
Publicado: (2021)

Potential Metabolic and Behavioural Roles of the Putative Endo- cannabinoid Receptors GPR18, GPR55 and GPR119 in Feeding
por: Ramírez-Orozco, Ricardo E., et al.
Publicado: (2019)

Chemistry and Hypoglycemic Activity of GPR119 Agonist ZB-16
por: Tyurenkov, Ivan N., et al.
Publicado: (2018)

OR24-01 Mutational Study of the GPR119 Receptor Binding Site
por: Rosales, Matthew D, et al.
Publicado: (2020)

Activation and signaling mechanism revealed by GPR119-G(s) complex structures
por: Qian, Yuxia, et al.
Publicado: (2022)

Microbial biotransformation to obtain stilbene methylglucoside with GPR119 agonistic activity
por: Peng, Yu, et al.
Publicado: (2023)

GPR119 agonist enhances gefitinib responsiveness through lactate-mediated inhibition of autophagy
por: Im, Ji Hye, et al.
Publicado: (2018)

Angelica dahurica Extracts Improve Glucose Tolerance through the Activation of GPR119
por: Park, Eun-Young, et al.
Publicado: (2016)

Correction: GPR119 agonist enhances gefitinib responsiveness through lactate-mediatedinhibition of autophagy
por: Im, Ji Hye, et al.
Publicado: (2022)

A GPR119 Signaling System in the Murine Eye Regulates Intraocular Pressure in a Sex-Dependent Manner
por: Miller, Sally, et al.
Publicado: (2017)

Bile acid composition regulates GPR119-dependent intestinal lipid sensing and food intake regulation in mice
por: Higuchi, Sei, et al.
Publicado: (2020)

Peptide YY Is Critical for Acylethanolamine Receptor Gpr119-Induced Activation of Gastrointestinal Mucosal Responses
por: Cox, Helen M., et al.
Publicado: (2010)

Intestinal GPR119 activation by microbiota-derived metabolites impacts feeding behavior and energy metabolism
por: Igarashi, Miki, et al.
Publicado: (2022)

Phospholipase D2 controls bone homeostasis by modulating M-CSF-dependent osteoclastic cell migration and microtubule stability
por: Kim, Hyun-Ju, et al.
Publicado: (2022)

Stimulating β-Cell Regeneration by Combining a GPR119 Agonist with a DPP-IV Inhibitor
por: Ansarullah,, et al.
Publicado: (2013)

Lipid derivatives activate GPR119 and trigger GLP-1 secretion in primary murine L-cells
por: Hodge, Daryl, et al.
Publicado: (2016)

Bidirectional GPR119 Agonism Requires Peptide YY and Glucose for Activity in Mouse and Human Colon Mucosa
por: Tough, Iain R, et al.
Publicado: (2018)

Formation of βTC3 and MIN6 Pseudoislets Changes the Expression Pattern of Gpr40, Gpr55, and Gpr119 Receptors and Improves Lysophosphatidylcholines-Potentiated Glucose-Stimulated Insulin Secretion
por: Drzazga, Anna, et al.
Publicado: (2020)

In Vivo Efficacy of HD0471953: A Novel GPR119 Agonist for the Treatment of Type 2 Diabetes Mellitus
por: Kim, So Ra, et al.
Publicado: (2013)

$^{119}$Sn Mössbauer study of the implantation behaviour of $^{119}$In, $^{119}$Sn, $^{119m}$Sn, $^{119}$Sb and $^{119m}$Te ions in SiC
por: Petersen, J W, et al.
Publicado: (1985)

The decay of $]^{119}$Cd and $\^{119}$In isomers
por: Scheidemann, O, et al.
Publicado: (1976)

ZB-16, a Novel GPR119 Agonist, Relieves the Severity of Streptozotocin–Nicotinamide-Induced Diabetes in Rats
por: Tyurenkov, Ivan N., et al.
Publicado: (2017)

Activation of GPR119 Stimulates Human β-Cell Replication and Neogenesis in Humanized Mice with Functional Human Islets
por: Ansarullah,, et al.
Publicado: (2016)

Targeting the GPR119/incretin axis: a promising new therapy for metabolic-associated fatty liver disease
por: Zhao, Jianan, et al.
Publicado: (2021)

Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice
por: McKillop, Aine M., et al.
Publicado: (2016)

DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice
por: Kim, Youjin, et al.
Publicado: (2022)

High-Throughput Screening for GPR119 Modulators Identifies a Novel Compound with Anti-Diabetic Efficacy in db/db Mice
por: Zhang, Meng, et al.
Publicado: (2013)

$\beta$ and $\gamma$-spectroscopy study of $^{119}$Pd and $^{119}$Ag
por: Kurpeta, J, et al.
Publicado: (2022)

Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells
por: Ning, Y, et al.
Publicado: (2008)

The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivo
por: Huan, Yi, et al.
Publicado: (2017)

Optimisation of novel 4, 8-disubstituted dihydropyrimido[5,4-b][1,4]oxazine derivatives as potent GPR 119 agonists
por: Fang, Yuanying, et al.
Publicado: (2019)

Docosahexaenoic acid inhibits TNF-α-induced osteoclast formation and orthodontic tooth movement through GPR120
por: Ma, Jinghan, et al.
Publicado: (2023)

Docosahexaenoic Acid Inhibits Inflammation-Induced Osteoclast Formation and Bone Resorption in vivo Through GPR120 by Inhibiting TNF-α Production in Macrophages and Directly Inhibiting Osteoclast Formation
por: Kishikawa, Akiko, et al.
Publicado: (2019)

Klaviertücke Op.119
por: Brahms, Johannes, 1833-1897
Publicado: (1976)

Large-Scale Production of (119m)Te and (119)Sb for Radiopharmaceutical Applications
por: Bennett, Kevin T., et al.
Publicado: (2019)

Upregulated insulin secretion in insulin-resistant mice: evidence of increased islet GLP1 receptor levels and GPR119-activated GLP1 secretion
por: Ahlkvist, L, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g0ihe26o58ahk48nst6c39lcmj